<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00538941</url>
  </required_header>
  <id_info>
    <org_study_id>EK1124_Chocolate_CHF</org_study_id>
    <nct_id>NCT00538941</nct_id>
  </id_info>
  <brief_title>Effects of Chocolate in Patients With Chronic Heart Failure</brief_title>
  <official_title>Effects of Swiss Dark Chocolate on Endothelial and Baroreceptor Function and Markers of Inflammation in Patients With Chronic Heart Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to investigate whether in patients with chronic heart failure
      endothelial dysfunction and baroreceptor function is altered by ingestion of a flavonoid-rich
      dark chocolate in comparison to placebo chocolate (Nestlé Placebo Chocolate) on top of
      standard medication.

      Moreover, we will evaluate the effect of chocolate on oxidative stress, platelet adhesion as
      well as systemic inflammatory response such as C-reactive protein and pro-inflammatory
      cytokines in patients with chronic heart failure.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2005</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>endothelial function</measure>
    <time_frame>acute (2 hours), chronic (2 and 4 weeks)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>shear-stress dependent platelet function; Oxidative stress; baroreceptor function Systemic inflammatory response (assessed as change in high sensitivity CRP, 8-Isoprostanes, CD-40 ligand); Plasma epicatechins.</measure>
    <time_frame>acute (2 hours), chronic (2 and 4 weeks)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">22</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>daily intake of 40gr chocolate (Nestlé Noir intense) in the morning and 40gr chocolate in the evening.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Nestlé Placebo Chocolate 40gr in the morning and 40gr chocolate in the evening.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nestlé Noir intense 40 grx2</intervention_name>
    <description>daily intake of 40gr chocolate (Nestlé Noir intense or Nestlé Placebo Chocolate) in the morning and 40gr chocolate in the evening.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Nestlé Placebo Chocolate 40 grx2</intervention_name>
    <description>Nestlé Placebo Chocolate 40 gr in the morning and 40gr chocolate in the evening.</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Heart failure ( NYHA ≥II, LVEF&lt;50%, independent of aetiology)

          2. Nonsmokers

          3. Age: 30-80

          4. Written obtained informed consent

        Exclusion Criteria:

          1. Decompensated Heart failure

          2. Instable Angina pectoris

          3. Smokers

          4. Ventricular tachyarrhythmias or AV-Block &gt;I°

          5. Renal failure (&gt;200 umol)

          6. Liver disease (ALT or AST &gt;150 IU)

          7. Diabetes mellitus

          8. Obesity (BMI &gt;30 kg/m2)

          9. Symptomatic hypotension, hypertension &gt;160/100mmHg

         10. Known allergy to compounds of Nestlé noir intense

         11. History of gastric ulcer or bleeding, current diarrhea

         12. Venous thrombosis or pulmonary embolism, at present or recurrent history of Infectious
             disease, acutely or chronic

         13. Disease with systemic inflammation (e.g. rheumatoid arthritis, M. Crohn)

         14. Neoplasia (unless healed or remission &gt;5 years)

         15. Participation in another study within the last month

         16. Concomitant vitamin supplements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Georg Noll, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cardiovascular Center, University Hospital Zurich, Zurich, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardiovascular Center, Cardiology, University Hospital of Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 1, 2007</study_first_submitted>
  <study_first_submitted_qc>October 2, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 3, 2007</study_first_posted>
  <last_update_submitted>October 27, 2009</last_update_submitted>
  <last_update_submitted_qc>October 27, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 28, 2009</last_update_posted>
  <responsible_party>
    <name_title>PD Dr. med. Roberto Corti</name_title>
    <organization>University of Zurich</organization>
  </responsible_party>
  <keyword>chocolate,</keyword>
  <keyword>heart failure,</keyword>
  <keyword>endothelial function,</keyword>
  <keyword>platelet adhesion,</keyword>
  <keyword>oxidative stress,</keyword>
  <keyword>baroreceptor function,</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

